CF
ORGO icon

Corebridge Financial’s Organogenesis Holdings ORGO Stock Holding History

Corebridge Financial’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,539
Closed -$145K – 1930
2025
Q1 		$145K Sell
33,539
-2,350
-7% -$9.49K ﹤0.01% 2250
2024
Q4 		$115K Sell
35,889
-2,709
-7% -$9.09K ﹤0.01% 2486
2024
Q3 		$110K Sell
38,598
-238
-0.6% -$667 ﹤0.01% 2568
2024
Q2 		$109K Buy
+38,836
New +$104K ﹤0.01% 2552

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corebridge Financial's ORGO Position: Q2 2025 in Review

Corebridge Financial sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 33,539 shares — an estimated $145K sold.

Corebridge Financial first reported a position in ORGO in Q2 2024 and held it in 4 quarters. The position peaked at $145K in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Corebridge Financial reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 33,539 Organogenesis Holdings shares in Q2 2025, an estimated $145K.
  • Corebridge Financial first reported a position in Organogenesis Holdings in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Organogenesis Holdings position peaked at $145K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.